Wealthcreatures.com
1.42K subscribers
1.19K photos
48 videos
40 files
1.54K links
Visit us at www.wealthcreatures.com

Driven by Fundamentals and Leveraging Technicals.

All post are Only For Study & Educational Purpose.consult you Financial Advisor Before Investing or taking any position.
DISCLAIMER:We r Not SEBI REGISTERED ANALYST.
Download Telegram
Laurus Labs CEO Says Richcore Lifesciences’ Acquisition Will Fast-Track Biotech Ambitions


Pharmaceutical ingredients maker Laurus Labs Ltd. has found its “fourth lever of growth” in the biotech space, according to its Chief Executive Satyanarayana Chava, and its most recent acquisition will fast-track this ambition.

“The gestation period to enter the biotech space is a 6-7-year period,” he told BloombergQuint’s Menaka Doshi in an interview. “Our idea is to cut down this gestation period significantly by making an acquisition.”

Laurus Labs, on Nov. 26, closed a Rs 250-crore deal to acquire a majority stake in Richcore Lifesciences, marking its entry into the biotech space and adding to its existing three divisions - active pharmaceutical ingredients, formulations and synthesis.

The startup’s promoters and management will continue to run the business while Laurus Labs—having acquired just over 72% stake—will allow the company to scale its manufacturing.The acquisition marks Laurus Labs’ entry into the broader biologics and biotechnology segments, providing the company access to its high growth areas, globally and in India. Following the successful closure of the transaction, Richcore will be renamed as Laurus Bio Pvt.

Chava expects a significant return from the investment to come from Richcore’s contract manufacturing of recombinant proteins. The startup’s first large-scale facility —with a 2,50,000 litre capacity—will be ready by March 2021.

“That’s where the quantum jump in revenues will come from.” Richcore clocked Rs 30 crore revenue in its first six months of this financial year.

Another such facility is slated to be built by the end of 2021.

View: Positive for Lauras Lab in longer run.
Wealthcreatures.com
IGL Accumulate 405 -409 Bigger Horizon SL 378 Short term 395 Advisable for A bit long TF T 440 / 490
IGL

10 % UPPER CIRCUIT

492

ALL TARGETS ACHIVED FOR SHORT TERM

BOOK PROFITS OR TRAIL WITH S/L 470 FOR NEXT T - 525/555++
CHEMICALS STOCKS GETTING READY FOR UP IN NEXT WEEK

KEEP ON RADAR
Wealthcreatures.com
EXPLEO Cmp - 475 - 480 Available at good discount To All Time High of 642 Expecting to reach all time high in next 3 To 6 months
EXPLEO

GOOD CONSOLIDATION HAS HAPPENED IN LAST FEW DAYS

GETTING READY FOR UPMOVE

ONCE CLOSED ABOVE 494 CAN SEE BIG MOVE IN COMING DAYS
MASTEK GETTING READY FOR NEXT LEG 🦵 OF RALLY ONCE CLOSED ABOVE 1012

STOCK HAS MADE GOOD BASE AROUND 940 - 955
ONE OUR FAVOURITE INVESTMENT PICK

THE SLEEPING LION

DEEPAK NITRITE

HAS JUST WOKE UP FROM ITS CONSOLIDATION & RANGE BREKOUT

NEW 52wk HIGH COMING 🔜

EXPECTING # 900/950++
SUN TV

ADD 50% AT CMP - 435

50% ON DIPS @420/415

SUPPORT @ 400/390

TEST LEVELS IN COMING DAYS # 450/475/500/525++

S/L - AS PER RISK
Deepak Nitrite Getting Ready

for

999++
KEEP BOOKING PROFITS IN INDIVIDUAL STOCKS AS PER TIME FRAME & RISK

OR

KEEP TRAILING
Update

DEEPAK NITRITE

863

Just 3% AWAY FROM 52wk HIGH